Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ألفه للأدوية - ulfa pharma co. - sevelamer hcl 800 mg - 800 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

genzyme europe b.v., netherlands - imiglucerase - powder for concentrate for solution for infusion - 400 u

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - imiglucerase, quantity: 10 ml (equivalent: imiglucerase, qty 400 u) - injection, powder for - excipient ingredients: citric acid monohydrate; nitrogen; polysorbate 80; sodium citrate dihydrate; mannitol - cerezyme (imiglucerase) is indicated for long-term enzyme replacement therapy for patients with a confirmed diagnosis of non-neuronopathic (type 1) or chronic neuronopathic (type 3) gaucher disease who exhibit clinically significant non-neurological manifestations of the disease. the non-neurological manifestations of gaucher disease include one or more of the following conditions: a) anaemia; - b) thrombocytopenia; - c) bone disease; - d) hepatomegaly or splenomegaly.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

sanofi-aventis (malaysia) sdn. bhd. - imiglucerase -